Dana D - Search Results

1

Deep Learning in Drug Discovery and Medicine; Scratching the Surface.

Dana D, Gadhiya SV, St Surin LG, Li D, Naaz F, Ali Q, Paka L, Yamin MA, Narayan M, Goldberg ID, Narayan P. Dana D, et al. Molecules. 2018 Sep 18;23(9):2384. doi: 10.3390/molecules23092384. Molecules. 2018. PMID: 30231499 Free PMC article. Review.

2

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.

Hwang A, Shi C, Zhu E, Naaz F, Zhou P, Rasheed Z, Liu M, Jung LS, Duan B, Li J, Jiang K, Paka L, Gadhiya SV, Dana D, Ali Q, Yamin MA, Goldberg ID, Narayan P. Hwang A, et al. Among authors: dana d. PLoS One. 2018 Jun 26;13(6):e0198937. doi: 10.1371/journal.pone.0198937. eCollection 2018. PLoS One. 2018. PMID: 29944670 Free PMC article.

3

A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L.

Dana D, Pathak SK. Dana D, et al. Molecules. 2020 Feb 6;25(3):698. doi: 10.3390/molecules25030698. Molecules. 2020. PMID: 32041276 Free PMC article. Review.

4

Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development.

Dana D, Das T, Choi A, Bhuiyan AI, Das TK, Talele TT, Pathak SK. Dana D, et al. Molecules. 2022 Jan 6;27(2):347. doi: 10.3390/molecules27020347. Molecules. 2022. PMID: 35056661 Free PMC article. Review.

5

Cell penetrable, clickable and tagless activity-based probe of human cathepsin L.

Dana D, Garcia J, Bhuiyan AI, Rathod P, Joo L, Novoa DA, Paroly S, Fath KR, Chang EJ, Pathak SK. Dana D, et al. Bioorg Chem. 2019 Apr;85:505-514. doi: 10.1016/j.bioorg.2019.02.032. Epub 2019 Feb 14. Bioorg Chem. 2019. PMID: 30802807

6

Clickable, selective, and cell-permeable activity-based probe of human cathepsin B - Minimalistic approach for enhanced selectivity.

Bhuiyan AI, Rathod P, Ghoshal S, Dana D, Das T, Li G, Dickson AA, Rafi F, Subramaniam GS, Fath KR, Paroly S, Chang EJ, Pathak SK. Bhuiyan AI, et al. Among authors: dana d. Bioorg Chem. 2021 Dec;117:105463. doi: 10.1016/j.bioorg.2021.105463. Epub 2021 Nov 2. Bioorg Chem. 2021. PMID: 34753058

7

Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach.

Dana D, De S, Rathod P, Davalos AR, Novoa DA, Paroly S, Torres VM, Afzal N, Lankalapalli RS, Rotenberg SA, Chang EJ, Subramaniam G, Kumar S. Dana D, et al. Chem Commun (Camb). 2014 Sep 25;50(74):10875-8. doi: 10.1039/c4cc04037f. Epub 2014 Aug 4. Chem Commun (Camb). 2014. PMID: 25089379

8

Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.

Dana D, Davalos AR, De S, Rathod P, Gamage RK, Huestis J, Afzal N, Zavlanov Y, Paroly SS, Rotenberg SA, Subramaniam G, Mark KJ, Chang EJ, Kumar S. Dana D, et al. Bioorg Med Chem. 2013 Jun 1;21(11):2975-87. doi: 10.1016/j.bmc.2013.03.062. Epub 2013 Apr 2. Bioorg Med Chem. 2013. PMID: 23623677

9

Design, synthesis, and evaluation of 2-(arylsulfonyl)oxiranes as cell-permeable covalent inhibitors of protein tyrosine phosphatases.

Dana D, Das TK, Kumar I, Davalos AR, Mark KJ, Ramai D, Chang EJ, Talele TT, Kumar S. Dana D, et al. Chem Biol Drug Des. 2012 Oct;80(4):489-99. doi: 10.1111/j.1747-0285.2012.01437.x. Epub 2012 Jul 25. Chem Biol Drug Des. 2012. PMID: 22726577

10

Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis.

Das TK, Dana D, Paroly SS, Perumal SK, Singh S, Jhun H, Pendse J, Cagan RL, Talele TT, Kumar S. Das TK, et al. Among authors: dana d. Oncogenesis. 2013 Sep 9;2(9):e69. doi: 10.1038/oncsis.2013.34. Oncogenesis. 2013. PMID: 24018644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page